News
	
	
	
		Efficacy and Safety of Fixed Combination of Olopatadine and Mometasone in Nasal Spray for Treatment of Seasonal Allergic Rhinitis
Patients with allergic rhinitis require medications with rapid onset and long duration of action. The combination of intranasal antihistamines and corticosteroids has proven effective in the past. The efficacy and safety of a fixed combination of olopatadine and mometasone in a nasal spray (GSP301) was evaluated in the study presented below by a team of American authors.
			Luck in Unluckiness: Influence of Anticoagulant Therapy on Severity of Stroke in Atrial Fibrillation
					A recent Swiss study evaluated the severity, complications, and outcomes of cerebrovascular…
			
	
			Gliflozins Successfully Treat Type 2 Diabetes Mellitus and Heart Failure
					The number of patients with type 2 diabetes mellitus (DM2) and heart failure is increasing…
			
	
			New Drug in the Biologic Therapy Arsenal for Plaque Psoriasis
					Bimekizumab shows promising effects in clinical studies with psoriasis patients. Let's take a…
			
	
			Ceftaroline vs. Vancomycin in the Treatment of Acute Pulmonary Exacerbation of Cystic Fibrosis
					Up to 25% of patients with cystic fibrosis are colonized with methicillin-resistant Staphylococcus…
			
	
			Safety of Long-Term Therapy with Bevacizumab in Oncological Patients
					The angiogenesis inhibitor bevacizumab is typically administered long-term. Therefore, a study…
			
	
			Effectiveness of Idarucizumab Reversal Effect
					It is, of course, a great advantage if doctors have a specific substance available that counteracts…
			
	
			Pain Management After Day Surgery
					Effective pain control is a crucial part of recovery for patients after painful surgical…
			
	
			Venetoclax Treatment Strategies in Patients with CLL
					One of the new targeted preparations in the treatment of chronic lymphocytic leukemia (CLL) is the…
			
	
			Efficacy of Lorlatinib in Patients with ROS1-Positive NSCLC in Clinical Practice
					Interesting real-world data have been brought by a study on the efficacy of lorlatinib in patients…